OS Therapies OSTX
NYSE OSTX
$1.29 +0.03 (+2.38%)
As of: Oct 21, 2026 · 3:59 PM EDT

OS Therapies (OSTX) Interest Expenses (2023 - 2026)

Updated

OS Therapies (OSTX) posted Interest Expenses of $5,581 for Q2 2026, down 92.6% from the prior quarter.

Analysis

OS Therapies (OSTX) Interest Expenses (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest Expenses at OS Therapies was $526,320; for FY2024, it was $2.05 million, down 40.5% from FY2023.

  • In prior years, OS Therapies' Interest Expenses was $3.45 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly Interest Expenses in data going back to Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 OS Therapies 6.11 Mn 2.84 Mn - 5,581.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,581.00
Mar 31, 2026 75,344.00
Dec 31, 2024 7,556.00
Sep 30, 2024 437,839.00
Jun 30, 2024 777,681.00
Mar 31, 2024 828,760.00
Dec 31, 2023 307,534.00
Sep 30, 2023 1.35 Mn
Jun 30, 2023 989,684.00
Mar 31, 2023 798,938.00
API Access

OS Therapies Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=OSTX&period=max&api_key=YOUR_API_KEY